Showing results (321-330 of 422) with videos related to
Sort By:
Pageof 43
Neurology|June 24, 2004
Quantitative measurement of pain sensation in patients with Parkinson diseaseR Djaldetti, A Shifrin, Z Rogowski, et al.Life Sciences|March 8, 1982
Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's diseaseJ H Growdon, E Melamed, M Logue, et al.Brain Research|December 3, 1986
Effect of serotonergic, corticostriatal and kainic acid lesions on the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in miceE Melamed, E Pikarski, A Goldberg, et al.American Journal of Physical Medicine & Rehabilitation|August 13, 2002
Brain injury-related heterotopic bone formation: treatment strategy and resultsE Melamed, D Robinson, N Halperin, et al.Neuropharmacology|October 1, 1982
Stimulation of nigrostriatal dopamine neurones by nicotineW Lichtensteiger, F Hefti, D Felix, et al.European Journal of Pharmacology|August 7, 1985
Mesolimbic dopaminergic neurons are not spared by MPTP neurotoxicity in miceE Melamed, J Rosenthal, M Globus, et al.European Journal of Pain (London, England)|April 5, 2012
Contribution of genetic variants to pain susceptibility in Parkinson diseaseL Greenbaum, I Tegeder, Y Barhum, et al.Immunological Investigations|August 1, 1995
IL-3-LA production by mononuclear cells of patients with multiple sclerosis: effect of treatment with intravenous immunoglobulinsR Djaldetti, A Achiron, I Ziv, et al.Cancer|January 21, 2000
Metastases to the retroperitoneum in patients with extremity soft tissue sarcoma: an unusual metastatic patternD Lev-Chelouche, R Nakache, D Soffer, et al.Immunology Letters|July 29, 1999
A novel antigen-toxin chimeric protein: myelin basic protein-pseudomonas exotoxin (MBP-PE 40) for treatment of experimental autoimmune encephalomyelitisT Brenner, I Steinberger, D Soffer, et al.Pageof 43